168 related articles for article (PubMed ID: 8044987)
1. Direct stopped-flow fluorescence polarization immunoassay of abused drugs and their metabolites in urine.
Pérez-Bendito D; Gómez-Hens A; Gaikwad A
Clin Chem; 1994 Aug; 40(8):1489-93. PubMed ID: 8044987
[TBL] [Abstract][Full Text] [Related]
2. Performance of Abusign drugs-of-abuse slide tests with particluar emphasis on concentrations near the cutoff: comparison with FPIA-ADx and confirmation of results with GC-MS.
Ros JJ; Pelders MG; Egberts AC
J Anal Toxicol; 1998; 22(1):40-4. PubMed ID: 9491967
[TBL] [Abstract][Full Text] [Related]
3. Monitoring urinary excretion of cannabinoids by fluorescence-polarization immunoassay: a cannabinoid-to-creatinine ratio study.
Fraser AD; Worth D
Ther Drug Monit; 2002 Dec; 24(6):746-50. PubMed ID: 12451292
[TBL] [Abstract][Full Text] [Related]
4. Development and evaluation of immunochromatographic rapid tests for screening of cannabinoids, cocaine, and opiates in urine.
Wennig R; Moeller MR; Haguenoer JM; Marocchi A; Zoppi F; Smith BL; de la Torre R; Carstensen CA; Goerlach-Graw A; Schaeffler J; Leinberger R
J Anal Toxicol; 1998; 22(2):148-55. PubMed ID: 9547412
[TBL] [Abstract][Full Text] [Related]
5. Interpretations of the TDxFLx calibration data of the abused drugs.
Sihn YS; Chung HS
Forensic Sci Int; 2003 Jan; 131(1):1-7. PubMed ID: 12505464
[TBL] [Abstract][Full Text] [Related]
6. Interference of common household chemicals in immunoassay methods for drugs of abuse.
Warner A
Clin Chem; 1989 Apr; 35(4):648-51. PubMed ID: 2539273
[TBL] [Abstract][Full Text] [Related]
7. Analytic performance of immunoassays for drugs of abuse below established cutoff values.
Luzzi VI; Saunders AN; Koenig JW; Turk J; Lo SF; Garg UC; Dietzen DJ
Clin Chem; 2004 Apr; 50(4):717-22. PubMed ID: 14764642
[TBL] [Abstract][Full Text] [Related]
8. Papain: a novel urine adulterant.
Burrows DL; Nicolaides A; Rice PJ; Dufforc M; Johnson DA; Ferslew KE
J Anal Toxicol; 2005; 29(5):275-95. PubMed ID: 16105251
[TBL] [Abstract][Full Text] [Related]
9. Comparison of LUCIO®-direct ELISA with CEDIA immunoassay for 'zero tolerance' drug screening in urine as required by the German re-licensing guidelines.
Agius R; Nadulski T; Kahl HG; Dufaux B
Drug Test Anal; 2013 Jun; 5(6):390-9. PubMed ID: 23349145
[TBL] [Abstract][Full Text] [Related]
10. The effects of adulterating agents on FPIA analysis of urine for drugs of abuse.
Schwarzhoff R; Cody JT
J Anal Toxicol; 1993; 17(1):14-7. PubMed ID: 8429620
[TBL] [Abstract][Full Text] [Related]
11. The determination of drugs of abuse in whole blood by means of FPIA and EMIT-dau immunoassays--a comparative study.
Bogusz M; Aderjan R; Schmitt G; Nadler E; Neureither B
Forensic Sci Int; 1990 Nov; 48(1):27-37. PubMed ID: 2279719
[TBL] [Abstract][Full Text] [Related]
12. Determination of five abused drugs in nitrite-adulterated urine by immunoassays and gas chromatography-mass spectrometry.
Tsai SC; ElSohly MA; Dubrovsky T; Twarowska B; Towt J; Salamone SJ
J Anal Toxicol; 1998 Oct; 22(6):474-80. PubMed ID: 9788522
[TBL] [Abstract][Full Text] [Related]
13. Cross-reactivity of selected compounds in the Abbott TDx cannabinoid assay.
ElSohly MA; Jones AB; ElSohly HN
J Anal Toxicol; 1990; 14(5):277-9. PubMed ID: 2175818
[TBL] [Abstract][Full Text] [Related]
14. The analytical performance of six urine drug screens on cobas 6000 and ARCHITECT i2000 compared to LC-MS/MS gold standard.
Abou El Hassan M; Colantonio D; Likhodii S; Nassar BA
Clin Biochem; 2021 Jul; 93():99-103. PubMed ID: 33844982
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of false-negative urine cannabinoid immunoassay screens by Visine eyedrops.
Pearson SD; Ash KO; Urry FM
Clin Chem; 1989 Apr; 35(4):636-8. PubMed ID: 2467764
[TBL] [Abstract][Full Text] [Related]
16. Fluorescence polarization immunoassay for the detection of drugs of abuse in human whole blood.
Keller T; Schneider A; Dirnhofer R; Jungo R; Meyer W
Med Sci Law; 2000 Jul; 40(3):258-62. PubMed ID: 10976190
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody urine assay for amphetamines, cocaine and cannabinoids: a pilot study of Mexican athletes.
Padilla J; Eguíalis MC; Mendoza F; Santos VA; Ojeda P
Proc West Pharmacol Soc; 2002; 45():191-2. PubMed ID: 12434578
[No Abstract] [Full Text] [Related]
18. A broad spectrum immunoassay using fluorescence polarization for the detection of amphetamines in urine.
Turner GJ; Colbert DL; Chowdry BZ
Ann Clin Biochem; 1991 Nov; 28 ( Pt 6)():588-94. PubMed ID: 1776809
[TBL] [Abstract][Full Text] [Related]
19. Comparison of ELISAs for opiates, methamphetamine, cocaine metabolite, benzodiazepines, phencyclidine, and cannabinoids in whole blood and urine.
Kerrigan S; Phillips WH
Clin Chem; 2001 Mar; 47(3):540-7. PubMed ID: 11238309
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of drugs of abuse in urine of drivers involved in road accidents in France: a collaborative study.
Marquet P; Delpla PA; Kerguelen S; Bremond J; Facy F; Garnier M; Guery B; Lhermitte M; Mathé D; Pelissier AL; Renaudeau C; Vest P; Seguela JP
J Forensic Sci; 1998 Jul; 43(4):806-11. PubMed ID: 9670503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
